SS Innovations International (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, an accolade that recognizes excellence in innovation, commercial success, industry leadership and positive societal impact. The award reflects the increasing adoption of the company's SSi Mantra surgical robotic system, which is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.
As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also stated that approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries. These milestones underscore the system's expanding clinical footprint and the company's commitment to making robotic surgery more accessible.
The award is significant because it validates SS Innovations' strategy of offering a cost-effective alternative to established robotic surgery systems, potentially broadening access to minimally invasive surgery in underserved markets. The company's focus on affordability and training aligns with global healthcare trends aiming to reduce costs while improving patient outcomes. With regulatory approvals in 14 countries and a growing library of procedures, the SSi Mantra system is positioned to compete in the global surgical robotics market, which is expected to grow substantially in the coming years.
For more details on the award announcement, the full press release is available at https://ibn.fm/XWdRe. Information about SS Innovations and its products can be found on the company's website at ssinnovations.com.
